Stay ahead of the science. For you, or someone you love.
Clinical Trial Monitoring and Weekly Research Briefings
TrialsAlert monitors clinical trials on ClinicalTrials.gov daily, classifies them by potential impact using AI, and delivers weekly research briefings in plain English to patients and caregivers tracking specific medical conditions.
How it works
1. Enter your condition
Tell us what you or your loved one is dealing with. We use AI to understand the medical terminology and find every relevant clinical trial.
2. We scan daily
Every day, we scan ClinicalTrials.gov for new and updated trials. Our AI scores each trial for relevance, phase, and potential impact on your condition.
3. You get a weekly briefing
Every Friday, you receive a plain-language research briefing explaining what changed this week, which trials matter most, and why. No jargon, no noise.
4. Share with your doctor
Generate a professional clinical trial report you can bring to your next appointment or email directly to your physician.
Simple pricing
Single Track
Track 1 medical condition. EUR 11 per month or EUR 24 per quarter (save 27%). Includes weekly AI research briefings, trial matching, plain English summaries, and doctor report generation.
Universal Access
Track up to 3 medical conditions. EUR 19 per month or EUR 42 per quarter (save 27%). Everything in Single Track, plus monitoring for multiple conditions simultaneously.
Start monitoring your condition
Trusted by patients and caregivers
Maria S., Caregiver, breast cancer: "I used to spend hours every week searching for updates on my mother's condition. Now I get everything in one briefing on Friday morning. I brought the report to her oncologist and he didn't even know about that Phase 3 trial. It changed the conversation completely."
James R., Patient, type 2 diabetes: "I've been living with type 2 diabetes for 12 years. TrialsAlert is the first service that actually tells me what's new in research without the medical jargon. The weekly briefing is the first email I open every Friday."
Sophie L., Community advocate, psoriasis: "I run a psoriasis support group with 400 members. When I share findings from my TrialsAlert briefing, people message me saying it's the most useful thing anyone has posted. It gives me credible, sourced content to share."
Frequently Asked Questions about Clinical Trial Monitoring
Where does the data come from?
ClinicalTrials.gov, a US government database maintained by the National Library of Medicine. We scan over 400,000 clinical trials.
Is this medical advice?
No. TrialsAlert helps you stay informed about clinical research. Always discuss findings with your healthcare provider before making medical decisions.
Can I cancel anytime?
Yes. One click, no questions asked. Your subscription ends at the current billing period.
What if there is nothing new for my condition?
You will still receive a weekly briefing confirming we are monitoring. Research activity varies. Some weeks are busy, others quiet. You will know either way.
How is this different from searching ClinicalTrials.gov myself?
You could search yourself, but there are over 400,000 trials. We scan daily, match what is relevant to you, classify trials by impact, and explain them clearly. That is 5+ hours of research, done for you, every week.
Conditions We Monitor
We track clinical trials across all medical conditions on ClinicalTrials.gov. Popular conditions include:
- Type 2 Diabetes
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Alzheimer's Disease
- Obesity
- Psoriasis
- Multiple Sclerosis
- Crohn's Disease
- Rheumatoid Arthritis
- Multiple Myeloma
- Parkinson's Disease
- Melanoma
- Leukemia
- COPD
- Heart Failure
- Lupus
- Epilepsy
- Sickle Cell Disease
- ALS
Patient Guides to Clinical Trials
- How to Find Clinical Trials for Your Condition
- Clinical Trial Phases Explained
- How to Talk to Your Doctor About Clinical Trials
- Understanding Clinical Trial Results
Clinical Trial Glossary
50+ clinical trial terms explained in plain language. View the full glossary: adverse event, biomarker, blinding, clinical endpoint, control group, double-blind, efficacy, eligibility criteria, endpoint, FDA, hazard ratio, informed consent, NNT, Phase 1, Phase 2, Phase 3, Phase 4, placebo, p-value, randomization, standard of care, statistical significance, and more.